BM
Bala Murali Krishna Thippabhotla
About Bala Murali Krishna Thippabhotla
Data last updated:
Bala Murali Krishna Thippabhotla is a Director at Apogen Remedies Private Limited (since 2019), Director at Bago Laboratories Private Limited (since 2008) and Designated Partner at Exarmed Pharma Llp (since 2024). The companies operate in Pharma and Chemicals and Materials. The 2 current companies with reported revenue have a combined latest revenue of ₹9.07 Cr; the largest is Apogen Remedies Private Limited at ₹8.63 Cr (FY 2025). Earlier, Bala Murali Krishna Thippabhotla was a Whole-Time Director at Alphamed Formulations Private Limited (2012–2018) and Director at Exarmed Pharma Private Limited (from 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Apogen Remedies Private Limited U24232TG2011PTC075363 | Director | 19 Jul 2019 | 2011 | ₹8.63 Cr (FY 2025) | Active |
 Bago Laboratories Private Limited U24239TG2002PTC038340 | Director | 01 May 2008 | 2002 | ₹44.2 Lakh (FY 2025) | Active |
| Exarmed Pharma Llp ACI-6222 | Designated Partner | 27 Jul 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alphamed Formulations Private Limited U24239TG2006PTC051732 | Whole-Time Director | 26 Sep 2012 | 2006 | ₹197 Cr (FY 2025) | Active |
| Exarmed Pharma Private Limited U24110TG2019PTC129565 | Director | 01 Jul 2019 | 2019 | ₹23.3 Lakh (FY 2023) | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Bala Murali Krishna Thippabhotla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhishek Shukla | Apogen Remedies Private Limited | Company Secretary | |
| Bhanu Prasad Kommineni | 01408377 | Apogen Remedies Private Limited | Director |
| Tamma Raghava Srinivasa Reddy | 02509720 | Apogen Remedies Private Limited | Director |
| Vikram Bery | 02166843 | Apogen Remedies Private Limited , Bago Laboratories Private Limited | Director |
| Vajrala Bhulakshmi | 08324004 | Exarmed Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bala Murali Krishna Thippabhotla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bala Murali Krishna Thippabhotla
Bala Murali Krishna Thippabhotla currently holds 3 directorships: Apogen Remedies Private Limited (Director, since 19 Jul 2019, revenue ₹8.63 Cr (FY 2025)); Bago Laboratories Private Limited (Director, since 01 May 2008, revenue ₹44.2 Lakh (FY 2025)); Exarmed Pharma Llp (Designated Partner, since 27 Jul 2024).
Bala Murali Krishna Thippabhotla was first appointed on 01 May 2008 as Director at Bago Laboratories Private Limited. The most recent appointment on record is 27 Jul 2024 at Exarmed Pharma Llp.
The 2 current companies of Bala Murali Krishna Thippabhotla that report revenue have a combined latest revenue of ₹9.07 Cr: Apogen Remedies Private Limited ₹8.63 Cr (FY 2025); Bago Laboratories Private Limited ₹44.2 Lakh (FY 2025).
Bala Murali Krishna Thippabhotla held 2 earlier board appointments: Alphamed Formulations Private Limited (Whole-Time Director, 26 Sep 2012 to 30 Nov 2018); Exarmed Pharma Private Limited (Director, from 01 Jul 2019).
The current boards of Bala Murali Krishna Thippabhotla's companies include Abhishek Shukla (Apogen Remedies Private Limited), Bhanu Prasad Kommineni (Apogen Remedies Private Limited), Tamma Raghava Srinivasa Reddy (Apogen Remedies Private Limited), Vikram Bery (Apogen Remedies Private Limited), Vajrala Bhulakshmi (Exarmed Pharma Llp).